Comorbidities to Breast Cancer

The most prevalent comorbidities related to carcinoma are hypertension (21.8%), chronic obstructive pulmonary disease (COPD) (19.9%), rheumatologic disease (18.6%), and diabetes (16.7%), all four conditions are reported in around 75% of the cases.

Pre-existing comorbidities negatively impacts overall carcinoma prognosis, increasing both carcinoma specific deaths furthermore as death from competing causes. Improvements in carcinoma survival in recent decades, however, have primarily been experienced among cancer patients without comorbidities, and fewer so among those with moderate or severe comorbidities. Information regarding treatment effectiveness in carcinoma patients with comorbidities is currently lacking. This chapter describes the impact of comorbidities on carcinoma treatment and outcomes, previous research approaches taken, and specific populations that will be most prone to the results of comorbidities on carcinoma outcomes. Future research directions are suggested that will help to enhance understanding of comorbidity-related factors that underlie disparities in carcinoma outcomes, and to look at the potential role of effective management of comorbidities among carcinoma patients as a method to assist close gaps in disease prognosis.

 

    Related Conference of Comorbidities to Breast Cancer

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Comorbidities to Breast Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in